Broker Center sponsored links

Pfizer shares drop on Chantix research

Wed May 21, 2008 4:39pm EDT
 
Email | Print | | Reprints | Single Page
[-] Text [+]

NEW YORK (Reuters) - Shares of Pfizer Inc (PFE.N: Quote, Profile, Research, Stock Buzz) fell 1.3 percent in trading after the bell on Wednesday, after U.S. researchers said data showed serious side effects with the company's smoking drug, Chantix.

Shares fell to $19.74 from its close of $20.01 on the New York Stock Exchange.

(Reporting by Kristina Cooke)

 

Featured Broker sponsored link

Editor's Choice

  • Pictures
  • Video
  • Articles
Photo

A selection of our best photos from the past 24 hours.  View Slideshow 

Most Popular on Reuters

  • Articles
  • Video
  • Recommended